LSE:CRTX - CRISM Therapeutics Corporation joined the list of notable AIM market decliners after falling 7.73% during trading on June 9, 2026. The decline reflects broader investor caution surrounding biotechnology companies, particularly those operating in development-stage healthcare segments where future success depends heavily on …
LSE:CIZ - Cizzle Biotechnology Holdings PLC came under selling pressure on June 9, 2026, declining 7.87% and joining the list of notable AIM market fallers. The decline reflects a combination of investor caution toward early-stage healthcare businesses, ongoing commercialisation challenges and broader weakness across …
LSE:ALNA - Alina Holdings PLC became one of the notable decliners on the AIM market after falling 10.38% during trading on June 9, 2026. The sharp decline reflects a combination of company-specific sentiment, broader weakness across small-capGrowth Stocksand continued investor caution regarding healthcare-sector execution …
The healthcare industry continues to benefit from favorable demographic trends, increasing healthcare spending, innovation in pharmaceuticals, and growingDemandfor specialized healthcare solutions. These structural factors have helped position Uniphar as an important participant within the healthcare distribution and services ecosystem.
AstraZeneca PLC is one of the world's leading biopharmaceutical companies, focused on developing and commercializing innovative medicines across oncology, cardiovascular, renal, metabolism, respiratory, immunology, vaccines, and rare diseases. With a strong global presence and an extensive research pipeline, the company has established itself as …
GSK PLC is one of the world's leading biopharmaceutical companies, focused on developing and commercializing innovative medicines, vaccines, and specialty healthcare products. Following its strategic transformation in recent years, the company has sharpened its focus on pharmaceuticals and vaccines, positioning itself as a research-driven …
RTW Biotech Opportunities Ltd (LSE:RTW) traded lower today as investors reassessed biotechnology-sector valuations and growth expectations amid broader market uncertainty. TheInvestmentcompany focuses on biotechnology, life sciences, and healthcare innovation businesses, providing exposure to some of the most advanced areas of medical research andDrug Development.
Oxford Nanopore Technologies plc (LSE:ONT) traded higher today as investors increased exposure to high-growth biotechnology and genomics companies. The company has established itself as a leading innovator in nanopore-based DNA and RNA sequencing technology, serving researchers, healthcare providers, pharmaceutical companies, and academic institutions across …
IntroductionCraneware plc (LSE:CRW) is a healthcare-technology company that helps US hospitals and health systems improve their financial performance, margins and operational efficiency. With a highly recurring, subscription-basedRevenuemodel delivered through its Trisus cloud platform, Craneware (CRW) has built a reputation as a quality compounder on …
IntroductionAdvanced Medical Solutions Group plc (LSE:AMS) is a UK-based medical-technology company specialising in tissue-healing and surgical products, including wound closure, sealants and biosurgical devices. Best known for its LiquiBand tissue adhesives, Advanced Medical Solutions (AMS) has expanded its reach throughAcquisitioninto surgical sutures and related …